- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 7/02 - Acyclic radicals
Patent holdings for IPC class C07H 7/02
Total number of patents in this class: 127
10-year publication summary
9
|
10
|
5
|
6
|
6
|
9
|
6
|
9
|
14
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
TFChem | 37 |
7 |
Ultragenyx Pharmaceutical Inc. | 181 |
7 |
Avilar Therapeutics, Inc. | 28 |
7 |
The Regents of the University of California | 19887 |
6 |
Vertex Pharmaceuticals Incorporated | 1599 |
5 |
BELLUS Health Inc. | 13 |
5 |
The Research Foundation for The State University of New York | 1615 |
4 |
L' Oréal | 5511 |
3 |
L'OREAL, Société Anonyme | 15429 |
2 |
Nestec S.A. | 2669 |
2 |
Centre National de La Recherche Scientifique | 10418 |
2 |
The Johns Hopkins University | 5662 |
2 |
President and Fellows of Harvard College | 5972 |
2 |
Alchemia Limited | 3 |
2 |
Gilead Sciences, Inc. | 2036 |
2 |
Jiangnan University | 1525 |
2 |
National University of Singapore | 2443 |
2 |
Phytoquest Limited | 16 |
2 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2847 |
2 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3143 |
2 |
Other owners | 59 |